Psychiatric HPI for Medication Management Follow-Up Visits

Core Components

The American Psychiatric Association recommends evaluating target symptoms that were the focus of initial medication management, including any changes in severity, frequency, or impact on functioning 1, 2
A comprehensive psychiatric review of systems should include anxiety symptoms, panic attacks, sleep disturbances, and impulsivity, as suggested by the American Journal of Psychiatry 1, 3
The American Academy of Child and Adolescent Psychiatry suggests using standardized rating scales to track symptom changes objectively 4
The American Journal of Psychiatry recommends reviewing current medication adherence patterns, including missed doses and reasons for non-adherence, and documenting response to current medications, including degree of symptom improvement 1, 2, 3

The Journal of the American Academy of Child and Adolescent Psychiatry notes that medication side effects, particularly those common to psychiatric medications, such as sleep disturbances, appetite changes, weight fluctuations, and sexual dysfunction, should be assessed 4, 5
The Journal of Internal Medicine suggests evaluating for any new drug-drug interactions with changes in medication regimen 6

The American Journal of Psychiatry recommends assessing changes in social, occupational, and educational functioning since the last visit 1
JAMA network open suggests documenting impact of current symptoms and medication effects on quality of life, and evaluating self-care abilities and need for additional support services 7

The American Journal of Psychiatry recommends screening for current suicidal or homicidal ideation, plans, or intent, and assessing for any aggressive behaviors or thoughts since the last visit 1, 2, 3

The American Journal of Psychiatry suggests reviewing current use of tobacco, alcohol, and other substances, and documenting any changes in substance use patterns since the previous visit 1, 2, 3

The Journal of Internal Medicine recommends noting any new medical diagnoses, hospitalizations, or procedures since the last visit, and documenting changes to non-psychiatric medications 1, 3, 6
JAMA network open suggests identifying any new psychosocial stressors that may be affecting symptom presentation, and documenting changes in social support, housing, or financial circumstances 7
The Journal of the American Academy of Child and Adolescent Psychiatry notes that systematic assessment of common side effects is essential, as patients may not associate physical symptoms with psychiatric medications 4, 5
The American Journal of Psychiatry recommends always reviewing the complete medication list, including over-the-counter medications and supplements, to identify potential drug-drug interactions 1, 6

Approximately one-third of psychiatric patients express a need for psychological intervention, with anxiety, younger age, and impaired social support increasing this demand 8
Psychosocial distress predicts treatment failure: patients with psychological distress have difficulty processing clinically relevant information, leading to poor treatment adherence and increased emergency visits 8, 9
The American Academy of Psychiatry recommends screening for anxiety and depression at regular visits, as psychological distress contributes to poor quality of life and increased healthcare utilization regardless of primary psychiatric diagnosis severity 8

Patients expressing explicit need for psychological intervention should be referred for additional care 8
Those with anxiety, younger age, or impaired social support should be considered for referral 8
When detection of psychological distress could improve health-related quality of life, referral for additional psychosocial intervention is recommended 8

Never allow patient-driven agenda to completely override systematic symptom assessment, as patients may be reluctant to reveal emotional problems due to stigma, but failure to inquire leads to missed diagnoses and treatment failures 9
Do not assume stable psychiatric symptoms mean psychosocial assessment is unnecessary, as psychosocial factors predict healthcare utilization and relapse independent of symptom severity 8

The American Academy of Child and Adolescent Psychiatry recommends asking patients to rate the severity of their symptoms on a scale of 0-10, compared to the last visit, to track changes in symptom severity 10
The American Academy of Pediatrics suggests asking patients about the frequency of specific symptoms, such as "How many days this week did you experience [specific symptom]?" to monitor symptom frequency 11
The American Academy of Child and Adolescent Psychiatry recommends using standardized rating scales, such as the PHQ-9 for depression and GAD-7 for anxiety, to objectively track changes in symptoms 10

The American Academy of Pediatrics recommends systematically inquiring about common medication-specific side effects, such as changes in sleep, appetite, or weight, as patients often fail to connect physical symptoms with psychiatric medications 11
The American Academy of Child and Adolescent Psychiatry suggests asking patients about sedation or daytime tiredness, as well as extrapyramidal symptoms, such as stiffness, tremor, or restlessness, to screen for potential side effects 10
The American Academy of Pediatrics recommends asking patients about increased anxiety, agitation, or feeling 'revved up' when taking SSRIs/SNRIs, as well as thoughts of harming themselves, to monitor for potential adverse effects 11

The European Heart Journal recommends monitoring blood pressure, pulse, weight, and height, particularly in children and adolescents, to detect potential metabolic changes and cardiovascular effects caused by psychotropic medications 12
The European Heart Journal suggests asking patients about cardiac symptoms, such as chest pain, palpitations, or feeling like they might pass out, when taking medications with known QT-prolonging effects 12

The American Academy of Pediatrics recommends discussing the duration of treatment with patients, maintaining medication for 6-12 months after full symptom resolution, or up to 2 years for recurrent episodes, to ensure sustained improvement 11
The American Academy of Child and Adolescent Psychiatry suggests considering a medication-free trial to reassess diagnosis if treatment-resistant, and obtaining psychiatric consultation for complex cases 10